Literature DB >> 12807949

Chapter 11: Future directions in cervical pathology.

Mark E Sherman1.   

Abstract

Technologic innovations, including the development of improved sampling devices, liquid-based collection systems, and computer-assisted screening, have revolutionized cervical cytology. Biologic discoveries in upcoming years promise to transform our understanding of the pathogenesis of cervical neoplasia, leading to another quantum leap in our approach to screening and prevention. This review summarizes the opportunities and challenges that recent and anticipated advances in pathology present for epidemiologic research.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12807949     DOI: 10.1093/oxfordjournals.jncimonographs.a003486

Source DB:  PubMed          Journal:  J Natl Cancer Inst Monogr        ISSN: 1052-6773


  4 in total

1.  Cost-effectiveness of cervical cancer screening with human papillomavirus DNA testing and HPV-16,18 vaccination.

Authors:  Jeremy D Goldhaber-Fiebert; Natasha K Stout; Joshua A Salomon; Karen M Kuntz; Sue J Goldie
Journal:  J Natl Cancer Inst       Date:  2008-02-26       Impact factor: 13.506

2.  Cost-effectiveness of cervical cancer screening with primary human papillomavirus testing in Norway.

Authors:  E A Burger; J D Ortendahl; S Sy; I S Kristiansen; J J Kim
Journal:  Br J Cancer       Date:  2012-03-22       Impact factor: 7.640

3.  Human papillomavirus type 16 long control region and E6 variants stratified by cervical disease stage.

Authors:  Luigi Marongiu; Anna Godi; John V Parry; Simon Beddows
Journal:  Infect Genet Evol       Date:  2014-05-10       Impact factor: 3.342

4.  Cervical HPV infection and neoplasia in a large population-based prospective study: the Manchester cohort.

Authors:  J Peto; C Gilham; J Deacon; C Taylor; C Evans; W Binns; M Haywood; N Elanko; D Coleman; R Yule; M Desai
Journal:  Br J Cancer       Date:  2004-08-31       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.